دسترسی نامحدود
برای کاربرانی که ثبت نام کرده اند
برای ارتباط با ما می توانید از طریق شماره موبایل زیر از طریق تماس و پیامک با ما در ارتباط باشید
در صورت عدم پاسخ گویی از طریق پیامک با پشتیبان در ارتباط باشید
برای کاربرانی که ثبت نام کرده اند
درصورت عدم همخوانی توضیحات با کتاب
از ساعت 7 صبح تا 10 شب
دسته بندی: جراحی ، ارتوپدی ویرایش: 2 نویسندگان: Chandrasen K. Sinha, Mark Davenport سری: ISBN (شابک) : 3030844668, 9783030844660 ناشر: Springer سال نشر: 2022 تعداد صفحات: 570 زبان: English فرمت فایل : PDF (درصورت درخواست کاربر به PDF، EPUB یا AZW3 تبدیل می شود) حجم فایل: 14 مگابایت
در صورت تبدیل فایل کتاب Handbook of Pediatric Surgery به فرمت های PDF، EPUB، AZW3، MOBI و یا DJVU می توانید به پشتیبان اطلاع دهید تا فایل مورد نظر را تبدیل نمایند.
توجه داشته باشید کتاب کتاب راهنمای جراحی اطفال نسخه زبان اصلی می باشد و کتاب ترجمه شده به فارسی نمی باشد. وبسایت اینترنشنال لایبرری ارائه دهنده کتاب های زبان اصلی می باشد و هیچ گونه کتاب ترجمه شده یا نوشته شده به فارسی را ارائه نمی دهد.
نسخه جدید و کاملاً بهروز شده این کتاب مروری مختصر از همه موضوعات مهم ارائه میکند و برای ارائه اطلاعاتی برای شناخت و درمان بیماریهای رایج جراحی کودکان: یعنی علائم و نشانهها، بررسی و مدیریت طراحی شده است. یک تمرین منطقی و مبتنی بر شواهد با استفاده از نمودارهای جریان، جداول و الگوریتم ها تشویق می شود. این نسخه به طور کامل بازنگری شده است تا منعکس کننده پیشرفت سریع در دنیای جراحی کودکان از جمله فوق تخصص های جراحی عمومی کودکان، اورولوژی، جراحی کبد صفراوی، پیوند اعضا، جراحی کم تهاجمی (از جمله جراحی رباتیک) و جراحی چاقی باشد. این کتاب همچنین زمینه تشریحی و فیزیولوژیکی را برای کمک به درک فراهم می کند.
این کتاب که توسط رهبران بین المللی در این زمینه ها تالیف شده است، پوشش جامعی از شرایط مختلف جراحی در کودکان مبتلا به فرمت مرجع سریع.
نسخه اول با بیش از 160000 بارگیری از جمله پزشکان عمومی،
پزشکان A&E، جراحان بزرگسالی که نیاز به درمان کودکان دارند،
پزشکان اطفال و البته، بسیار محبوب بوده است. جراحان
اطفال.
The new, fully updated edition of this book gives a concise overview of all important topics and is designed to provide information to recognise and treat common pediatric surgical conditions: namely, symptoms and signs, investigation, and management. A logical, evidence-based practice is encouraged by the use of flow charts, tables, and algorithms. This edition has been thoroughly revised to reflect the rapid progress in the world of pediatric surgery including the subspecialties of general pediatric surgery, urology, hepatobiliary surgery, organ transplantation, minimally invasive surgery (including robotic surgery), and bariatric surgery. This book also provides an anatomical and physiological background to aid understanding.
Having been authored by international leaders in these fields, this book offers comprehensive coverage of various surgical conditions in children with a quick-reference format.
The first edition has been immensely popular with over
160,000 downloads including GPs, A&E doctors, adult
surgeons who need to treat children, pediatricians, and of
course, pediatric surgeons.
Contents 1: Milestones in Pediatric Surgery Part I: Principles of Surgical Science 2: Transitional Physiology and Newborn Care 2.1 Fetal Circulation 2.2 Respiratory Adaptation 2.3 Newborn Physiology 2.4 Immediate Management After Birth 2.4.1 Thermoregulation 2.4.2 Cord Care 2.4.3 Feeding 2.5 Problems of the Premature 2.5.1 Respiratory Management 2.5.2 Thermoregulation 2.5.3 Jaundice 2.5.4 Anemia 2.6 Neonatal Infections 2.6.1 Investigations 2.6.2 Management 2.7 Fluid Management 2.8 Neonatal Nutrition Further Reading 3: Fluids, Electrolytes, and Dehydration 3.1 Normal Fluid Physiology 3.2 Age-Related Changes 3.3 Normal Fluid and Electrolyte Requirements 3.4 Insensible Fluid Loss 3.5 Postoperative Fluid Regimens 3.6 Dehydration 3.6.1 Infective Causes 3.6.2 Surgical Causes 3.6.3 Management 3.7 Specific Electrolyte Problems 3.7.1 Potassium 3.7.1.1 Hyperkalemia (<5.5 mmol/L) 3.7.1.2 Hypokalemia 3.7.2 Calcium 3.7.2.1 Hypocalcemia (Always Check Magnesium Levels Additionally) 3.7.2.2 Hypercalcemia 3.8 Acid-Base Imbalance 3.8.1 Concepts 3.8.2 Base Excess (or Deficit) 3.8.3 Abnormal Acid-Base States 3.8.3.1 Metabolic Acidosis 3.8.3.2 Metabolic Alkalosis Further Readings 4: Metabolic Response to Injury and Sepsis 4.1 Metabolic Response to Surgery 4.1.1 Factors Responsible for the Early Phase Response Include 4.1.2 Factors Responsible for the Late Response Phase Include 4.1.3 Tissue Response to Injury 4.2 Systemic Inflammatory Response Syndrome (SIRS) 4.3 Multiple Organ Dysfunction Syndrome (MODS) Further Reading 5: Shock 5.1 Classification 5.2 Degree of Shock 5.3 Clinical Features 5.3.1 Differences with Age 5.4 Management 5.4.1 Principles 5.4.2 Colloids Versus Crystalloids 5.4.3 Massive Transfusion Further Reading 6: Hematology for Surgeons 6.1 Coagulation Tests 6.1.1 Normal Process of Coagulation 6.1.2 Hemophilia 6.1.3 Blood Transfusion (UK Specific) 6.1.3.1 ABO System 6.1.3.2 Rhesus (D) System 6.1.3.3 Minor Groups 6.1.4 Need for Blood Transfusion 6.1.4.1 Platelets 6.1.4.2 Fresh Frozen Plasma 6.1.4.3 Cryoprecipitate 6.1.5 Transfusion Reactions 6.1.6 Alternatives to Blood Transfusion (Jehovah’s Witness) 6.1.7 Coombs’ Test 6.1.7.1 Transmissible Hazards of Blood Transfusion 6.1.8 Sickle Cell Disease 6.1.8.1 Sickle Cell Crisis 6.1.8.2 Clinical Features 6.1.9 Surgery in the Child with SCD 6.1.10 Acute Chest Syndrome 6.1.10.1 Management 6.1.11 Leucocytosis or Neutropenia Further Reading 7: Post-operative Recovery 7.1 Analgesia 7.1.1 Concepts: Pre-emptive and Multimodal Analgesia 7.1.2 Local Anesthesia (LA) 7.1.2.1 Percentage Solution of Local Anesthetics 7.1.2.2 Adrenaline (Epinephrine) 7.2 Pyrexia 7.2.1 Immediate (<24 h) 7.2.2 Early (2–5 Days) 7.2.3 Late (>5 Days) 7.3 Wound Infection 7.3.1 Organisms 7.3.2 Necrotizing Fasciitis 7.4 Clavien–Dindo Classification of Complications Further Reading 8: Parenteral Nutrition 8.1 Introduction 8.2 Indications for Parenteral Nutrition (PN) 8.3 Constituents of PN 8.3.1 Energy 8.3.2 Carbohydrate 8.3.3 Amino Acid 8.3.4 Lipid 8.3.5 Trace Elements and Vitamins 8.4 Initiation, Adjustment, and Monitoring of PN 8.4.1 Anthropometry 8.4.2 Biochemistry 8.4.3 Initiating PN 8.5 Complications of PN 8.6 Concomitant Medications 8.7 Long-Term Use of PN 8.8 Intestinal Failure-Associated Liver Disease (IFALD) 8.9 Multidisciplinary Team (MDT) Further Reading Part II: Trauma and Resuscitation 9: Trauma Management: General Principles 9.1 Basic Approach to Trauma 9.1.1 Important Differences Between Children and Adults 9.2 Management Plan 9.2.1 Primary Survey and Resuscitation 9.2.2ABCDE: Approach 9.2.3 Life-Threatening Conditions 9.2.4 Other Procedures During Resuscitation 9.2.5 Secondary Survey 9.2.6 Emergency Treatment 9.2.7 Reassessment and System Control 9.2.8 Continuing Stabilization and Definitive Care 9.3 Important Points About Systemic Injuries 9.3.1 Chest Trauma 9.3.1.1 Tension Pneumothorax 9.3.1.2 Flail Chest 9.3.1.3 Cardiac Tamponade 9.3.1.4 Abdominal Trauma 9.3.1.5 Head and Spine Injury 9.4 Supplemental Data 9.4.1 Physiological Further Reading 10: Head Injury 10.1 Introduction 10.2 Classification and Pathophysiology 10.3 Clinical Assessment 10.3.1 S-100B Protein 10.3.2 Imaging 10.4 Prevention of Head Injuries in Children Further Reading 11: Thoracic Trauma 11.1 Introduction 11.2 Mechanisms of Injury 11.3 Anatomy 11.3.1 Surface Landmarks 11.4 Principles of Management 11.5 Rib Cage Injury 11.5.1 Flail Chest 11.5.2 Non-accidental Trauma/Child Abuse 11.5.3 Investigation 11.5.4 Caveats and Atypical Injury 11.5.5 Management 11.6 Parenchymal Injury 11.6.1 Clinical Features 11.6.2 Investigation 11.6.3 Treatment 11.7 Pneumothorax 11.7.1 Investigation 11.7.2 Treatment 11.8 Hemothorax 11.8.1 Investigation 11.8.2 Treatment 11.9 Great Vessel Injury 11.9.1 Aortic Injury 11.10 Tracheobronchial Injury 11.11 Cardiac Injury 11.11.1 Commotio Cordis2 11.11.1.1 Investigations 11.11.2 Myocardial contusion 11.11.2.1 Investigations 11.11.3 Treatment 11.12 Diaphragm Injury 11.12.1 Investigation 11.12.2 Treatment 11.13 Esophageal Rupture 11.13.1 Investigation 11.13.2 Treatment 11.14 Traumatic Asphyxia (a.k.a. Crush Asphyxia) (Perthes3 Syndrome) Further Reading 12: Abdominal Trauma 12.1 Epidemiology 12.2 Mechanism of Injury 12.2.1 Factors Predisposing to Abdominal Injury in the Child 12.3 Clinical Features 12.4 Management (See Also Chap. 9) 12.4.1 Investigations and Imaging 12.4.2 Hemodynamically “Unstable” vs. “Stable” 12.4.3 Nonoperative Management of Blunt Abdominal Trauma (∼95%) 12.4.4 Interventional Radiology 12.5 Laparotomy for Abdominal Trauma (∼5%) 12.5.1 Principles 12.6 Penetrating Injuries 12.6.1 Laparotomy 12.7 Specific Organ Injury 12.7.1 Splenic Injury 12.7.1.1 Surgical Options 12.7.2 Liver Injury 12.7.2.1 Surgical Options 12.8 Renal Injury 12.9 Pancreatic Injury Further Reading Part III: Neonatal Surgery 13: Developmental Lung Lesions 13.1 Embryology 13.2 Prenatal Diagnosis 13.3 Pulmonary Agenesis 13.4 Bronchopulmonary Sequestration (BPS) 13.4.1 Clinical Features 13.4.2 Postnatal Investigations 13.4.3 Postnatal Management 13.5 Congenital Cystic Adenomatoid Malformation 13.5.1 Classification 13.5.2 Clinical Presentation 13.5.3 Management 13.6 Congenital Lobar Emphysema 13.6.1 Clinical Features 13.6.2 Management 13.7 Bronchogenic Cyst 13.7.1 Clinical Features 13.7.2 Management Further Reading 14: Esophageal Atresia 14.1 Background 14.1.1 VACTERL (Previously VATER) Association 14.1.2 CHARGE Syndrome 14.1.3 Embryology 14.2 Clinical Features 14.2.1 Prenatal 14.2.2 Postnatal Features and Investigation 14.2.2.1 Management 14.3 Surgery 14.3.1 Esophageal Atresia and Distal TEF 14.3.2 “Long-Gap” Esophageal Atresia 14.3.3 Surgical Complications 14.4 Thoracoscopic Repair 14.5 Prognostic Classifications 14.6 Long-Term Outcomes Further Reading 15: Congenital Diaphragmatic Hernia 15.1 Epidemiology 15.2 Associations 15.3 Embryology 15.4 Pulmonary Hypoplasia 15.5 Clinical Features 15.5.1 Antenatal 15.5.2 Postnatal 15.6 Management 15.6.1 Delivery Suite 15.6.2 In the Intensive Care Unit 15.6.3 Second-Line Therapy 15.7 Surgery 15.8 Complications and Outcome 15.9 Contentious Topics 15.9.1 Fetal Surgery 15.9.2 Minimally Invasive Surgery of CDH Further Reading 16: Congenital Pyloric Stenosis 16.1 Historical Aspects 16.2 Demographics 16.2.1 Risk Factors 16.2.2 Genetic Component 16.2.3 Associations 16.3 Pathophysiology 16.4 Clinical Features 16.4.1 Differential Diagnosis 16.4.2 Diagnosis 16.4.3 Management 16.4.4 Ramstedt’s Operation 16.4.5 Postoperative Care Further Reading 17: Intestinal Atresia 17.1 Epidemiology 17.2 Embryology 17.3 Associations 17.4 Classification (After Bland-Sutton, Modified by Grosfeld) 17.5 Clinical Features 17.5.1 Investigations 17.5.2 Differential Diagnosis 17.6 Surgery 17.6.1 Duodenal Atresia (Duodenoduodenostomy) 17.6.2 Jejunal Atresia (Figs. 17.2 and 17.3) 17.6.3 Colon Atresia 17.7 Outcome Further Reading 18: Intestinal Malrotation 18.1 Introduction 18.2 Embryology (After Frazer and Robbins) 18.3 Etiology 18.4 Clinical Features 18.4.1 Investigations 18.4.1.1 Prenatal: Very Unusual 18.4.1.2 Postnatal (Table 18.1) 18.5 Management 18.5.1 Surgery: Ladd’s Procedure 18.5.2 Asymptomatic Patients 18.6 Outcome and Complications Further Reading 19: Necrotizing Enterocolitis 19.1 Epidemiology 19.2 Pathogenesis 19.3 Prevention 19.4 Clinical Features and Diagnosis 19.5 Management 19.6 Surgical Options 19.7 Outcomes Further Reading 20: Meconium Ileus and Surgical Features of Cystic Fibrosis 20.1 Meconium Ileus 20.1.1 Definition 20.1.2 History 20.1.3 Epidemiology 20.2 Cystic Fibrosis 20.2.1 Pathophysiology 20.2.1.1 Lungs 20.2.1.2 Gastrointestinal Epithelium 20.3 Clinical Features of Meconium Ileus 20.3.1 Antenatal Period 20.3.2 Postnatal 20.3.3 Complicated MI 20.3.4 Investigations 20.3.4.1 Laboratory Tests 20.3.5 Management 20.3.5.1 Surgery (re-use original figures) 20.3.5.2 Postoperative care 20.3.6 Outcome 20.4 Meconium Plug Syndrome (MPS) 20.4.1 Clinical Features 20.5 Distal Intestinal Obstruction Syndrome (DIOS) 20.5.1 Clinical Features 20.5.2 Management 20.6 Fibrosing Colonopathy 20.7 Other Surgical Implications of CF 20.8 Malignancy 20.9 Gene Therapy of Cystic Fibrosis Further Reading 21: Abdominal Wall Defects 21.1 Introduction 21.2 Embryology 21.3 Exomphalos (Fig. 21.1) 21.3.1 Clinical Features 21.3.2 Investigations 21.3.3 Management 21.4 Gastroschisis (Fig. 21.2) 21.4.1 Clinical Features 21.4.2 Management 21.4.3 Surgery 21.4.4 Complications 21.4.5 Outcome Further Reading 22: Anorectal Malformations 22.1 Introduction 22.1.1 Epidemiology 22.1.2 Embryology 22.1.3 The Anatomical Classification 22.1.4 Associated Anomalies 22.1.5 Clinical Features 22.1.5.1 Males (Fig. 22.1) 22.1.5.2 Females (Fig. 22.2) 22.2 Neonatal Management 22.2.1 Surgical Management—Colostomy or Primary Repair? 22.2.2 Primary Perineal Approach 22.2.3 Colostomy 22.2.4 High-Pressure Distal Colostogram 22.2.5 Main Repair 22.2.5.1 PSARP 22.2.5.2 Recto-Bladder Neck Fistula 22.2.5.3 PSARP For Females with Recto-Vestibular Fistula (Fig. 22.4b and c) 22.2.5.4 Perineal Fistula in Females 22.2.5.5 Perineal Fistula in Males 22.2.5.6 Cloaca Common Channel <3 cm Common Channel >3 cm Further Reading 23: Hirschsprung’s Disease 23.1 Epidemiology 23.2 Embryology 23.3 Anatomy and Neuroanatomy 23.4 Genetics 23.5 Etiology 23.6 Pathology 23.6.1 Variable Affected Segment 23.7 Clinical Features 23.7.1 Investigations 23.7.2 Differential Diagnosis 23.8 Management 23.9 Surgery 23.9.1 Pull-Through Procedure 23.10 Outcome Further Reading Part IV: Hepatobiliary 24: Investigation of Jaundice 24.1 Metabolism of Bilirubin (Fig. 24.1) 24.2 Scale of Problem 24.3 Physiological Jaundice 24.4 Surgical Jaundice in Infants 24.4.1 Investigations 24.4.1.1 Ultrasonography (Table 24.1) 24.4.1.2 Liver Biopsy 24.4.1.3 Duodenal Aspiration 24.4.1.4 Radionuclear Isotope 24.4.1.5 Single Photon Emission Computed Tomography (SPECT) 24.4.1.6 Percutaneous Transhepatic Cholangiogam 24.4.1.7 Endoscopic Retrograde Cholangiopancreatography 24.4.1.8 Magnetic Resonance Cholangiopancreatography 24.4.1.9 Laparoscopy ± Cholangiography 24.5 Investigation of Surgical Jaundice in the Older Child 24.5.1 Intramural 24.5.2 Extramural 24.5.3 Mural Further Reading 25: Choledochal Malformation 25.1 History 25.2 Epidemiology 25.3 Classification 25.4 Pathogenesis 25.5 Clinical Features 25.5.1 Investigations 25.6 Surgery—Type 1c (Cystic Malformation) 25.7 Outcome Further Reading 26: Biliary Atresia 26.1 Epidemiology 26.2 Embryology 26.3 Classification 26.4 Clinical Features 26.4.1 Investigations 26.5 Surgery 26.5.1 Kasai Portoenterostomy (Fig. 26.2) 26.6 Complications 26.7 Outcome Further Reading 27: Gallbladder Disease 27.1 Congenital Anomalies of the Gallbladder 27.2 Gallstone Disease 27.2.1 Epidemiology 27.2.2 Predisposition Groups 27.2.3 Chemistry of Gallstones 27.2.4 Clinical Features 27.2.5 Investigations 27.2.6 Management 27.2.7 Surgery 27.3 Acalculous Cholecystitis 27.4 Hydrops of the Gallbladder 27.5 Biliary Dyskinesia 27.5.1 Investigation Further Reading 28: Pancreatic Disease 28.1 Embryology (Fig. 28.1) 28.1.1 Annular Pancreas 28.1.2 Pancreas Divisum 28.1.3 Common Channel 28.2 Acute Pancreatitis 28.2.1 Surgical Etiology 28.2.2 Medical Etiology 28.2.2.1 Hereditary (Aka Familial) Pancreatitis 28.2.3 Pathology of Pancreatitis 28.2.4 Clinical Features 28.2.5 Investigations 28.2.6 Management 28.2.6.1 Surgery 28.3 Chronic Pancreatitis 28.3.1 Etiology 28.3.2 Clinical Features 28.3.3 Investigations 28.3.4 Surgery 28.4 Persistent Hyperinsulinemic Hypoglycemia of infancy 28.4.1 Background 28.4.2 Associations 28.4.3 Pathology 28.4.4 Clinical features 28.4.5 Investigations 28.4.6 Management Further Reading 29: Portal Hypertension 29.1 Introduction 29.2 Anatomy 29.3 Causes of Portal Hypertension 29.3.1 Portal Vein Thrombosis 29.3.1.1 Aetiology 29.3.1.2 Clinical Features 29.3.1.3 Investigations 29.3.1.4 Management of Acute Bleeding Episode 29.3.1.5 Secondary Prophylaxis 29.3.1.6 Definitive Surgery Further Reading 30: Liver Transplantation 30.1 Indications for Transplantation 30.1.1 Acute Liver Failure 30.1.2 Chronic Liver Failure 30.1.3 Inborn Errors of Metabolism (~20%) 30.1.4 Liver Tumors (~10%) 30.2 Transplant Assessment 30.3 Surgery 30.3.1 Donor Allocation 30.3.2 Organ Donation 30.4 Surgery 30.4.1 Graft Preparation 30.4.2 Recipient Surgery 30.4.2.1 Post-Operative Care 30.4.3 Complications 30.4.3.1 Poor Graft Function 30.4.3.2 Vascular 30.4.3.3 Biliary Complications (up to 30%) 30.4.3.4 Rejection 30.4.3.5 Infection 30.5 Outcomes Further Reading Part V: Urology 31: Exstrophy-Epispadias Anomaly 31.1 Bladder Exstrophy-Epispadias Complex (BEEC) 31.1.1 Classical Bladder Exstrophy (CBE) 31.1.2 Cloacal Exstrophy 31.1.3 Epispadias 31.1.4 Genetics 31.2 Embryology 31.3 Clinical Features of BEEC 31.4 Objectives of Management 31.4.1 Modern Staged Repair of Bladder Exstrophy 31.4.2 Kelly Principle (Radical Soft Tissue Reconstruction) 31.4.3 Complete Primary Repair of Exstrophy 31.5 Complications 31.6 Outcome 31.7 Primary Epispadias 31.8 Cloacal Exstrophy 31.8.1 Surgical Principles Further Reading 32: Hypospadias 32.1 Embryology 32.1.1 Etiology 32.2 Clinical Features 32.2.1 Classification (Fig. 32.1) 32.3 Surgery 32.3.1 Principles 32.3.2 Preoperative Considerations 32.3.3 Surgical Techniques 32.3.3.1 Distal Hypospadias 32.3.3.2 Proximal Hypospadias 32.3.4 Postoperative Phase 32.4 Long-Term Outcome Further Reading 33: The Ureter 33.1 Anatomy and Embryology 33.2 Ureteropelvic Junction (UPJ) Obstruction 33.2.1 Etiology 33.2.2 Clinical Features 33.2.3 Investigations 33.2.3.1 Postnatal Ultrasonography: Primary Investigations Tool for Hydronephrosis 33.2.3.2 Radioisotope Scan 33.2.3.3 Treatment 33.2.3.4 Surgery 33.3 Duplex Anomalies 33.3.1 Clinical Features 33.3.2 Investigations 33.3.2.1 Ultrasound 33.3.2.2 VCUG (Voiding/Micturating Cystourethrogram) 33.3.2.3 Radio-Isotope Scan 33.3.2.4 MR Urography 33.3.2.5 Treatment 33.4 Ectopic Ureter 33.4.1 Clinical Features 33.4.2 Investigations 33.5 Surgery 33.6 Megaureter 33.6.1 Clinical Features 33.6.2 Investigations 33.6.3 Management 33.7 Ureteroceles 33.7.1 Types of Ureterocele 33.7.2 Clinical Features 33.7.2.1 Investigations 33.7.2.2 Surgery Further Reading 34: Vesicoureteric Reflux 34.1 Introduction 34.2 Pathology 34.3 Clinical Features 34.4 Investigations 34.4.1 Grading 34.5 Management 34.5.1 Reimplantation of Ureters 34.5.2 Complications 34.6 Outcome Further Reading 35: Posterior Urethral Valves 35.1 Anatomy 35.2 Classification 35.3 Epidemiology 35.4 Pathophysiology 35.4.1 Genetics 35.5 Clinical Features 35.5.1 Investigations 35.6 Management 35.7 Long-Term Management 35.7.1 Bladder Dysfunction and the “Valve Bladder” 35.7.1.1 VURD Syndrome 35.7.1.2 Hydroureteronephrosis (HUN) 35.8 Long-Term Outcomes 35.8.1 Renal Damage 35.8.2 End-Stage Renal disease 35.8.3 Renal Transplantation 35.8.4 Fertility Issues 35.8.5 Urinary Incontinence 35.8.6 Urinary Ascites (5–10%) 35.9 Antenatal Intervention Further Reading 36: Cryptorchidism 36.1 Anatomy 36.2 Embryology 36.3 Causes 36.4 Clinical Features 36.4.1 Associated Abnormalities 36.5 Management 36.5.1 Role of Hormone Therapy 36.5.2 Orchidopexy 36.5.3 Complications 36.5.4 Malignancy 36.5.4.1 Risk Factors 36.6 Outcome Further Reading 37: Inguinal Hernia Hydrocele and the Acute Scrotum 37.1 Abdominal Wall Hernia 37.2 Groin Hernia 37.2.1 Demography 37.2.2 Embryology 37.2.3 Contents of Hernia 37.2.4 Clinical Findings 37.2.4.1 Reducible Hernia 37.2.4.2 Incarcerated Hernia 37.2.4.3 Investigation 37.2.5 Management 37.2.5.1 Reducible Hernia 37.2.5.2 Incarcerated Hernia 37.2.5.3 Laparoscopic Repair 37.2.5.4 Contralateral Exploration 37.2.5.5 Hernia in Females 37.2.5.6 Overnight Admission 37.2.5.7 Outcome 37.3 Hydrocele 37.3.1 Classification 37.3.2 Clinical Features 37.3.3 Management 37.4 Abdominoscrotal Hydrocele 37.5 Acute Scrotum 37.5.1 Torsion of the Testis 37.5.1.1 Demography 37.5.1.2 Classification 37.5.1.3 Clinical Features 37.5.1.4 Investigations 37.5.1.5 Surgery 37.5.1.6 Manual Detorsion 37.5.1.7 Perinatal Testicular Torsion 37.5.1.8 Intermittent Testicular Pain 37.5.1.9 Outcome 37.6 Torsion of Testicular Appendages Further Reading 38: Neurogenic Bladder 38.1 Anatomy 38.2 Etiology 38.3 Classification 38.4 Clinical Evaluation 38.5 Basics of Urodynamics 38.6 Management of Neurogenic Bladder 38.6.1 Conservative Management 38.6.2 Surgical Management 38.6.2.1 Procedures to Augment Storage Capacity of Bladder 38.6.2.2 Complications of Cystoplasty 38.6.2.3 Mitrofanoff and Monti Continent Catheterizable Channels 38.6.2.4 Procedures to Improve Urinary Continence by Increasing Outlet Resistance 38.6.2.5 ACE Procedure 38.7 Transition to Adult Life Further Reading 39: Urinary Tract Infections 39.1 Introduction 39.2 Microbiology: Table 39.1 39.3 Risk Factors 39.4 Clinical Features 39.5 Investigations 39.5.1 Imaging 39.6 Treatment 39.7 Outcome Further Reading 40: Disorders of Sex Development 40.1 Embryology 40.2 Clinical Features 40.3 Investigations 40.4 Principles of Management 40.5 Gender Assignment 40.6 Long-Term Outcomes Further Reading 41: Enuresis 41.1 Introduction 41.2 Physiology 41.3 Causes of Enuresis 41.4 Clinical Features 41.4.1 Examination 41.4.2 Investigations 41.5 Management Part VI: Neurosurgery 42: Spina Bifida 42.1 Demography 42.2 Etiology 42.3 Embryology 42.4 Spina Bifida Occulta (SBO) 42.5 Spina Bifida Cystica 42.6 Managment 42.6.1 Prenatal 42.6.2 Postnatal 42.7 Surgery 42.7.1 Spinal Dysraphism (Lipomyeloceles, Dermal Sinus Tract, Tethered Cord) 42.8 Long Term Issues 42.8.1 Outcome Further Reading 43: Hydrocephalus 43.1 Physiology 43.2 Anatomy 43.3 Classification 43.3.1 Functional 43.3.2 Congenital or Acquired 43.4 Clinical Features 43.4.1 Imaging 43.4.2 Differential Diagnosis 43.5 Management 43.5.1 Medical 43.5.2 Surgical 43.5.2.1 Insertion of Shunt 43.5.2.2 Shunt Complications 43.5.2.3 Endoscopic Third Ventriculostomy 43.5.2.4 Choroid Plexectomy 43.6 Outcome Further Reading Part VII: Oncology 44: Wilms’ Tumor 44.1 Introduction 44.2 Epidemiology 44.2.1 Clinical Patterns 44.3 Genetics 44.4 Pathology 44.4.1 Pattern of Spread- 44.5 Clinical Features 44.5.1 Investigations 44.6 Histological Risk Stratification for Prenephrectomy Chemotherapy-Treated WT 44.7 Management 44.7.1 Surgery 44.7.2 Bilateral Wilms’ Tumor (Stage V) 44.7.3 Postoperative Chemotherapy Table 44.2 44.8 Prognosis Further Reading 45: Neuroblastoma 45.1 Introduction 45.2 Sites of Origin 45.3 Pathology 45.3.1 Shimada System Classification 45.3.2 Cytogenetics and Prognostic Factors 45.4 Clinical Features 45.4.1 Specific Investigations 45.5 Staging: Complex and Evolving 45.5.1 International Neuroblastoma Risk Group (INRG) Classification System 45.5.2 INRGSS: International Neuroblastoma Risk Group Staging System 45.5.3 International Neuroblastoma Staging System (INSS) 45.6 Management 45.6.1 Very Low-Risk Neuroblastoma 45.6.2 Low-Risk Neuroblastoma 45.6.2.1 Proposed Criteria for Observation 45.6.3 Intermediate-Risk Neuroblastoma 45.6.4 High-Risk Neuroblastoma 45.7 Fetal Tumors 45.8 Spinal Cord Compression 45.9 Surgery 45.10 New Treatments Further Reading 46: Liver Tumors 46.1 Introduction 46.2 Associations 46.3 Pathology 46.3.1 Hepatoblastoma 46.3.2 Hepatocellular Carcinoma 46.4 Clinical Features 46.4.1 Investigations 46.5 Staging 46.6 Management 46.6.1 Surgery 46.6.2 Outcome 46.7 Hepatic Metastases 46.8 Benign Liver Tumors 46.8.1 Hemangiomas (AKA Hemangioendotheliomas) 46.8.2 Pathology 46.8.3 Clinical Features 46.8.4 Investigations 46.8.5 Management 46.9 Mesenchymal Hamartomas 46.10 Focal Nodular Hyperplasia and Hepatic Adenomas 46.10.1 Investigations Further Reading 47: Teratomas 47.1 Introduction 47.1.1 Incidence 47.1.2 Embryology 47.1.3 Pathology and Classification (Fig. 47.1) 47.1.4 Staging 47.1.5 Tumor Markers 47.1.6 Risk Groups 47.1.7 Management 47.2 Sacrococcygeal Teratomas 47.2.1 Delivery 47.2.2 Surgery 47.2.3 Outcome Further Reading 48: Other Tumors 48.1 Lymphomas 48.1.1 Hodgkin’s Lymphoma 48.1.1.1 Etiology 48.1.1.2 Clinical Features 48.1.1.3 Investigations 48.1.1.4 Management 48.1.2 Non-Hodgkin’s Lymphoma 48.1.2.1 Etiology 48.1.2.2 Pathology 48.1.2.3 Clinical Features 48.1.2.4 Investigations 48.1.2.5 Management 48.1.3 Rhabdomyosarcoma 48.1.3.1 Etiology 48.1.3.2 Pathology and Genetics Cytogenetics 48.1.3.3 Investigations 48.1.3.4 Clinical Features 48.1.3.5 Management 48.1.3.6 Outcome 48.1.4 Malignant Melanoma 48.1.4.1 Clinical Features 48.1.4.2 Management 48.1.4.3 Prognosis 48.1.5 Pancreatic Tumors 48.1.5.1 Pancreatoblastoma 48.1.5.2 Islet Cell Hyperplasia 48.1.5.3 Solid Pseudopapillary Epithelial Neoplasm (Better Known as Frantz’s Tumor) 48.1.6 Thyroid Tumors 48.1.6.1 Etiological Factors 48.1.6.2 Clinical Features 48.1.6.3 Investigation 48.1.6.4 Surgery Further Reading Part VIII: Gastrointestinal 49: Gastro-Esophageal Reflux 49.1 Normal Physiology 49.2 Pathophysiology 49.3 Associations 49.4 Clinical Features 49.4.1 Relationship with Airway Problems 49.4.2 Investigations 49.5 Management 49.5.1 Medical 49.5.2 Surgery—Fundoplication (Fig. 49.1) 49.5.2.1 Indications 49.5.2.2 Relative Contraindications 49.5.2.3 Pre-Operative Evaluation 49.5.2.4 Surgical Principles 49.5.2.5 Procedure (Nissen, Thal, and Toupet) (Fig. 49.1) 49.5.2.6 Complications 49.5.2.7 Gastro-Jejunal Feeding 49.5.2.8 Other Surgical Interventions 49.6 Outcome Further Reading 50: Management of Gastrointestinal Bleeding 50.1 Background 50.1.1 Initial Presentation and Assessment 50.1.2 Management 50.1.2.1 Upper GI Bleed (Fig. 50.1) 50.1.2.2 Lower Gastrointestinal Bleeding (Fig. 50.3) Further Reading 51: Acute Abdomen 51.1 Clinical Features 51.1.1 Acute Appendicitis (See also Chap. 53) 51.1.2 Intussusception (See also Chap. 54) 51.1.3 Incarcerated Inguinal Hernia 51.1.4 Ovarian Torsion 52: Miscellaneous Causes of Abdominal Pain 52.1 Introduction 52.2 Functional Abdominal Pain Disorders 52.2.1 Functional Dyspepsia 52.2.2 Abdominal Migraine 52.2.3 Irritable Bowel Syndrome 52.3 Helicobacter Pylori 52.3.1 Clinical Features 52.3.2 Investigation 52.3.3 Eradication 52.4 Yersinia Infections 52.5 Pediatric Inflammatory Multisystem Syndrome (PIMS or PIMS-TS) 52.5.1 Key Clinical Features 52.6 Lead Poisoning (Painter’s Colic) 52.6.1 Clinical Features 52.6.2 Investigation 52.7 Porphyrias 52.7.1 Acute Intermittent Porphyria (AIP): Example 52.7.1.1 Clinical Features 52.7.1.2 Investigations 52.8 Familial Mediterranean Fever 52.8.1 Clinical Features 52.8.2 Investigation Further Reading 53: Acute Appendicitis 53.1 Epidemiology 53.2 Pathology 53.2.1 Reasons for Increased Perforation in the Young 53.3 Clinical Features 53.3.1 Named Signs in Appendicitis 53.4 Investigations 53.4.1 Investigations 53.5 Management 53.5.1 Timing 53.5.2 Open Appendicectomy 53.5.3 Laparoscopic Appendectomy 53.6 Outcome Further Reading 54: Intussusception 54.1 Epidemiology 54.2 Pathogenesis 54.3 Clinical Features 54.3.1 Investigations 54.4 Management 54.5 Surgery 54.5.1 Outcome 54.5.2 Laparoscopic Reduction Further Reading 55: Crohn’s Disease 55.1 Epidemiology 55.2 Etiology 55.3 Pathology 55.4 Clinical Features 55.5 Differential Diagnosis 55.6 Investigations 55.7 Management 55.7.1 Indications for Surgery 55.7.2 Surgical Options 55.7.2.1 Fistulas 55.7.2.2 Perianal disease 55.8 Outcome Further Reading 56: Ulcerative Colitis 56.1 Introduction 56.2 Epidemiology 56.3 Clinical Features 56.3.1 Investigations 56.4 Management 56.4.1 Surgical Treatment of UC 56.4.2 Complications Further Reading 57: Constipation 57.1 Introduction 57.2 Clinical Presentation 57.3 Laxatives 57.4 Investigations 57.4.1 X-rays 57.4.2 Rectal Biopsy 57.4.3 Transit Studies 57.4.4 Contrast Enema 57.4.5 Pelvic Ultrasound 57.4.6 Anorectal Manometry (ARM) 57.5 Role of Manual Evacuation 57.6 Role of Rectal Irrigation and Antegrade Continent Enema (ACE) 57.7 Role of Botox Injection in Anal Sphincter 57.8 Surgical Management with Sigmoid Colectomy with or Without Colostomy 58: Small Bowel Transplantation 58.1 History 58.2 Indications 58.3 Assessment 58.3.1 Abdominal Domain Expansion 58.3.2 Nutritional Preassessment 58.3.3 Evaluation of Central Veins 58.3.4 Viral Screening 58.4 Surgery 58.4.1 Donor Selection 58.4.2 Donor Surgery 58.4.2.1 Isolated Intestine Retrieval 58.4.2.2 Combined Liver and Intestine Retrieval 58.4.2.3 Multivisceral Graft Retrieval 58.4.3 Recipient Surgery 58.4.3.1 Isolated Intestinal Graft 58.4.3.2 Combined Liver and Intestinal Graft 58.4.3.3 Multivisceral Transplantation 58.4.4 Postoperative Care 58.4.5 Complications 58.4.5.1 Rejection (Common) 58.4.5.2 Sepsis 58.4.5.3 Post-transplant Lymphoproliferative Disease 58.4.5.4 Graft Versus Host Disease (GVHD) 58.5 Outcomes Further Reading Part IX: Miscellaneous 59: Surgical Neck Pathology 59.1 Introduction 59.2 Embryology 59.2.1 Branchial1 Arch Development 59.2.2 Thyroid Development 59.3 Branchial Fistula/Sinus/Cyst (Rare) 59.3.1 Clinical Features 59.3.2 Investigation 59.3.3 Surgery 59.4 Thyroglossal Duct Cyst 59.4.1 Clinical and Pathological Features 59.4.2 Investigation 59.4.3 Surgery: Sistrunk’s Operation 59.5 Cervical Node Infections (Common) 59.5.1 Clinical Features 59.6 Nontuberculous Mycobacterium (NTM) (Aka Atypical Mycobacterium) 59.6.1 Clinico-Pathology 59.6.2 Investigation 59.6.3 Management 59.7 Tuberculosis 59.8 Cat Scratch Disease or Fever, Felinosis 59.8.1 Clinical Features 59.8.2 Investigations 59.9 Kawasaki’s Disease 59.9.1 Clinical Features 59.9.2 Investigation 59.9.3 Management 59.10 Sternocleidomastoid “Tumor” (Rare) 59.10.1 Clinical Features 59.10.2 Investigation 59.10.3 Management 59.11 Lymphatic Malformations 59.11.1 Associations 59.11.2 Cystic Hygroma 59.11.2.1 Clinical Features 59.11.2.2 Investigation 59.11.2.3 Management 59.12 Dermoid Cysts and Epidermoid Cysts (Common) Further Reading 60: Fetal Surgery: General Principles 60.1 Introduction 60.2 Ethical Concerns 60.3 Accessing the Fetus 60.4 Specific Conditions 60.4.1 Congenital Diaphragmatic Hernia 60.4.2 Twin Anomalies 60.4.2.1 Twin-Twin Transfusion Syndrome 60.4.2.2 Twin Reversed Arterial Perfusion (TRAP) Sequence 60.4.3 Fetal Mass Lesions with Hydrops 60.4.4 Early Pregnancy Renal Anhydramnios 60.4.5 Bladder Outlet Obstruction (BOO) and Fetal Renal Failure 60.4.6 Myelomeningocele (Spina Bifida) 60.4.7 Aortic Valve Stenosis 60.4.8 Amniotic Band Syndrome 60.4.9 Congenital High Airway Obstruction Syndrome 60.5 The Future of Fetal Surgery Further Reading 61: Basic Pediatric Laparoscopy and Thoracoscopy 61.1 Introduction 61.2 General Principles 61.2.1 Positioning of the Patient and Port Placement 61.2.2 Pneumoperitoneum 61.2.3 Pneumothorax 61.2.4 Instrumentation 61.2.5 Standard Working Pressures 61.3 Pyloromyotomy for Pyloric Stenosis (See Chap. 16) 61.4 Laparoscopic Fundoplication and Gastrostomy Button (See Chap. 49) 61.4.1 Five-Port Nissen Technique 61.5 Malrotation and Ladd’s Procedure (See Chap. 19) 61.6 Thoracoscopic Procedures 61.6.1 Empyema 61.6.2 Technique 61.7 Esophageal Atresia Repair (See Chap. 14) 61.7.1 Technique Further Reading 62: Vascular Anomalies 62.1 Pathology 62.2 Hemangioma Versus Vascular Malformation 62.3 Specific Examples (Table 62.2) 62.3.1 Kasabach-Merritt Syndrome 62.3.2 Klippel-Trenaunay Syndrome (KTS) 62.3.3 Parkes Weber Syndrome (PWS) 62.3.4 Sturge-Weber Syndrome (SWS) 62.4 Investigations 62.5 Treatment 62.6 Complications Further Reading 63: Miscellaneous Surgical Issues 63.1 Tongue-Tie (Ankyloglossia) 63.1.1 Clinical Features 63.1.2 Management 63.2 Umbilical Issues 63.2.1 Embryology and Anatomy 63.2.2 Umbilical Hernia 63.2.2.1 Associations 63.2.2.2 Clinical Features 63.2.2.3 Management 63.2.2.4 Surgery 63.2.3 Umbilical swellings 63.3 Rectal Prolapse 63.3.1 Clinical Features 63.3.2 Differential 63.3.3 Investigations 63.3.4 Management 63.3.5 Surgery Further Reading 64: Bariatric Surgery 64.1 Definitions 64.2 Prevalence of Childhood/Adolescent Obesity 64.3 Clinical Features 64.4 Surgery 64.4.1 Preoperative Management 64.4.2 Bariatric Operations 64.5 Outcomes Further Reading 65: Airway Problems in Newborns and Children 65.1 Observations 65.2 Pathogenesis (Table 65.1) 65.3 Clinical Features (Table 65.2) 65.3.1 Stridor and Wheezing 65.4 Investigations 65.5 Management 65.5.1 Surgery of the Pediatric Airway Disorders 65.6 Outcomes Further Reading 66: Quality and Care Indicators 66.1 Introduction 66.2 What Is Quality? 66.2.1 Institute of Medicine: USA 66.2.2 Care Quality Commission (CQC): UK 66.3 How Can We Improve Quality? 66.3.1 Quality Improvement Approaches 66.3.2 Business Process Reengineering 66.3.3 Experience-Based Co-design 66.3.4 Lean 66.3.5 Model for Improvement (Including PDSA) 66.3.6 Six Sigma 66.3.7 Statistical Process Control 66.3.8 Theory of Constraints 66.4 Who Provides the Standards for Quality of Care? 66.5 Quality of Care in Pediatric Surgery Further Reading 67: Pediatric Orthopedics 67.1 Normal Variants in Early Years 67.2 Congenital Orthopedic Conditions 67.2.1 Developmental Dysplasia of Hip (DDH) (Fig. 67.1) 67.2.2 Congenital Talipes Equino-Varus (CTEV) 67.3 Acquired Orthopedic Conditions 67.3.1 Inflammation and Infection 67.3.2 Perthes Disease 67.3.3 Slipped Upper Femoral Epiphysis (SUFE) 67.3.4 Anterior Knee Pain in Adolescents 67.3.5 Osteochondritis at Various Stages of Growth 67.3.5.1 Kohler’s Disease of the Navicular 67.3.5.2 Sever’s Disease of the Calcaneum 67.3.5.3 Osgood-Schlatter’s Disease of the Tibial Tuberosity 67.3.5.4 Osteochondritis Dissecans of the Knee 67.3.6 Neoplasm, Benign, and Malign 67.3.6.1 Bone Cysts 67.3.6.2 Fibrous Dysplasia 67.3.6.3 Osteochondroma 67.3.6.4 Osteosarcoma Chondroblastoma 68: Robotic Pediatric Surgery 68.1 Introduction 68.2 The Da Vinci™ System and Other Robots 68.3 Advantages 68.4 Disadvantages 68.5 Indications 68.5.1 Urological Surgery 68.5.2 General Surgery 68.5.3 Cardiothoracic Surgery 68.5.4 Oncological Surgery 68.6 The Future Further Reading 69: Numerical References 69.1 Fluid Requirements (Table 69.1) 69.2 Normal Heart Rate; Respiratory Rate; Blood Pressure (Table 69.2) 69.3 Conversion Rates 69.4 Average and Normal (Table 69.4) 69.5 Normal Hematological Values (Table 69.5) 69.6 Calorie Requirements (Table 69.6) 69.7 Common Antibiotic Doses (Tables 69.7 and 69.8) 70: Anatomical References 70.1 Cranial Nerves 70.2 Dermatomes and Myotomes 70.3 Brachial Plexus 70.4 Segmental Liver Anatomy 70.5 The Lungs and Diaphragm 70.6 Heart 70.7 Gastrointestinal Tract 70.8 Genitourinary System 70.9 Inguinal Anatomy 70.10 Pharyngeal Arches 71: Human Developmental Milestones 71.1 Prenatal Development 71.1.1 “Egg” Phase: 1–4 Days 71.1.2 Embryo Phase 71.1.3 Fetal Phase 71.2 Ultrasound Scans in Pregnancy 71.3 Developmental Milestones Further Reading Index